Exome sequencing identifies FLNC and ADD3 variants in a family with cardiomyopathy

Abstract

Aim: Idiopathic cardiomyopathy is often genetic in origin, typically autosomal dominant, and restrictive cardiomyopathy (RCM) is the rarest form. Clinically, RCM prognosis is poor with most patients requiring heart transplant due to impaired diastolic function leading to heart failure. In some cases, desminopathy is also observed, whereby desmin protein aggregates in the myocardium. Many genes are known to be involved in cardiomyopathy, and we sought to find the pathogenic mutation of a four-generation family with RCM and desminopathy.

Methods: We employed whole exome sequence analysis of four RCM patients from the family, to identify the underlying pathogenic mutation(s).

Results: Analysis of the exome data led to identification of two putative pathogenic variants. One, a nonsense mutation in ADD3, encoding adducin 3, was found in the proband and his affected daughter, but not other family members. The other was a missense mutation (G1546S) in the gene encoding filamin C (FLNC), found in all of the affected individuals. Both of these proteins interact with proteins involved in sarcomere function, and are expressed in both heart and skeletal muscle. FLNC has recently been implicated as a cardiomyopathy gene, but ADD3 has not at this point.

Conclusion: We present bioinformatic analyses that suggest that the FLNC variant is the major pathogenic variant affecting this family, but cannot rule out some contribution of the ADD3 mutation in at least two patients.

Keywords

Restrictive cardiomyopathy / hypertrophic cardiomyopathy / FLNC / ADD3 / mutation / desmin / exome sequencing

References

[1] Maron BJ,Thiene G,Corrado D,Moss AJ,Young JB.Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the council on clinical cardiology, heart hailure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention..Circulation2006;113:1807-16

[2] Mogensen J.Restrictive cardiomyopathy..Curr Opin Cardiol2009;24:214-20

[3] Teekakirikul P,Rehm HL,Funke BH.Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era..J Mol Diagnostics2013;15:158-67

[4] Konta L,Kaski JP.Nomenclature and systems of classification for cardiomyopathy in children..Cardiol Young2015;25:31-42

[5] Richardson P,Bristow M,Mautner B,Olsen E,Goodwin J,Martin I.Report of the 1995 World Health Organization/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies..Circulation1996;93:841-2

[6] Stone JR.Updates to the WHO classification of cardiomyopathies..Acad Forensic Pathol2011;1:202-5

[7] Ho CY,Richard P,Van Spaendonck-Zwarts KY.Genetic advances in sarcomeric cardiomyopathies: state of the art..Cardiovasc Res2015;105:397-408 PMCID:PMC4349164

[8] Kostareva A,Gudkova A,Ruepp A,Ruepp A,Smolina N,Nilsson D,Khodyuchenko T,Pervunina T,Kozlenok A,Golovjova I,Shlyakhto E.Genetic spectrum of idiopathic restrictive cardiomyopathy uncovered by next-generation sequencing..PLoS One2016;11:e0163362 PMCID:PMC5035084

[9] Burke MA,Seidman JG.Clinical and mechanistic insights into the genetics of cardiomyopathy..J Am Coll Cardiol2016;68:2871-86 PMCID:PMC5843375

[10] Haas J,Peil B,Keller A,Feng Z,Kayvanpour E,Sedaghat-Hamedani F,Zhao X,Köhler D,Franke J,Barb I,Amr A,Mereles D,Hassel S,King V,Isnard R,Serio A,Syrris P,Plagnol V,Gadgaard T,Jørgensen M,Ortiz-Genga M,Deprez RH,van Rijsingen IA,Waldenstrom A,Bellazzi R,Bermejo JL,Villard E,Pinto YM,Elliott P,Katus HA.Atlas of the clinical genetics of dilated cardiomyopathy..Eur Heart J2015;36:1123-35

[11] Gallego-Delgado M,Brossa-Loidi V,Marzoa-Rivas R,Salazar-Mendiguchia J,Gonzalez-Lopez E,Bornstein B,Garcia-Pavia P.Idiopathic restrictive cardiomyopathy is primarily a genetic disease..J Am Coll Cardiol2016;67:3021-3

[12] Charron P,Arbustini E,Bilinska Z,Helio T,McKenna WJ,Pankuweit S,Rapezzi C,Seggewiss H,Tavazzi L.Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases..Eur Heart J2010;31:2715-26

[13] Ploski R,Ksiazczyk TM,Pollak A,Michalak E,Siolkowska L,Werner B.Evidence for troponin C (TNNC1) as a gene for autosomal recessive restrictive cardiomyopathy with fatal outcome in infancy..Am J Med Genet A2016;170:3241-8

[14] Yu HC,Geiger EA,Elias ER,Chatfield KC,Shaikh TH.Discovery of a potentially deleterious variant in TMEM87B in a patient with a hemizygous 2q13 microdeletion suggests a recessive condition characterized by congenital heart disease and restrictive cardiomyopathy..Cold Spring Harb Mol Case Stud2016;2:a000844 PMCID:PMC4853521

[15] Teo LY,Tang WH.Evolving approaches to genetic evaluation of specific cardiomyopathies..Curr Heart Failure Rep2015;12:339-49

[16] Towbin J.Inherited cardiomyopathies..Circ J2014;78:2347-56 PMCID:PMC4467885

[17] Brodehl A,Hamilton SJ,Brundler MA,Gibson WT,McGillivray B,Giuffre M,FORGE Canada Consortium.Mutations in FLNC are associated with familial restrictive cardiomyopathy..Hum Mutat2016;37:269-79

[18] Wu W,Wang YN,Chen W,Han YC,Zhang SY.Novel phenotype-genotype correlations of restrictive cardiomyopathy with myosin-binding protein C (MYBPC3) gene mutations tested by next-generation sequencing..J Am Heart Assoc2015;4:001879

[19] Zhang J,Kaplan L,Wallace MR.Genetic linkage of a novel autosomal dominant restrictive cardiomyopathy locus..J Med Genet2005;42:663-5 PMCID:PMC1736124

[20] Zhang J,Stalker H,Ferrans V,Fricker FJ.Clinical and molecular studies of a large family with desmin-associated restrictive cardiomyopathy..Clin Genet2001;59:248-56

[21] van der Ven PF,Lemke B,Weber K.Characterization of muscle filamin isoforms suggests a possible role of gamma-filamin/ABP-L in sarcomeric Z-disc formation..Cell Motil Cytoskeleton2000;45:149-62

[22] Sethi R.Small-angle X-ray scattering reveals compact domain-domain interactions in the n-terminal region of filamin C..PLoS One2014;9:e107457 PMCID:PMC4170960

[23] Molt S,Yakovlev S,Orfanos Z,Winter L,van der Van PF,Just S,Fürst DO.Aciculin interacts with filamin C and Xin and is essential for myofibril assembly, remodeling and maintenance.J Cell Sci2014;127:3578-92

[24] Ortiz-Genga MF,Dal Ferro M,Salgado-Aranda R,Padrón-Barthe L,Jiménez-Jáimez J,García-Campo E,Suárez-Mier MP,Marcos-Alonso S,Santomé JL,Rodríguez-Garrido JL,Merlo M,Pe-a ML,Martín-Vila A,Molina P,Calvo-Iglesias FE,Calò L,Gimeno-Blanes JR,García-Pavía P.Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies..J Am Coll Cardiol2016;68:2440-51

[25] Valdés-Mas R,Gómez J,Astudillo A,Reguero JR,Moris C,Martin M,López-Otín C.Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy..Nat Commun2014;5:5326

[26] Leber Y,Kirfel G,Hoffmann B,Bryson-Richardson RJ.Filamin C is a highly dynamic protein associated with fast repair of myofibrillar microdamage.Hum Mol Genet2016;25:2776-88

[27] Azzimato V,Tabish AM,Knoll R.Desmin, desminopathy, and the complexity of genetics..J Mol Cell Cardiol2016;92:93-5

[28] Tucker NR,Hu D,Parsons VA,Clauss S,Shea MA,Scott NS,Lubitz SA,Stone JR,Ellinore PT.Novel mutation in FLNC (filamin C) causes familial restrictive cardiomyopathy..Circ Cardiovasc Genet2017;10:e001780

[29] Gomez J,Reguero JR,Martin M,Alonso B,Alvarez V,Avanzas P.Screening of the filamin C gene in a large cohort of hypertrophic cardiomyopathy patients..Circ Cardiovasc Genet2017;10:e001584

[30] Avila-Smirnow D,Batonnet-Pichon S,Bécane H,K.,Goudeau B,Nelson I,Ben Yaou R,Wahbi K,Voit T,van der Ven P,Vicart P,Bonne G.Cardiac arrhythmia and late-onset muscle weakness caused by a myofibrillar myopathy with unusual histopathological features due to a novel missense mutation in FLNC..Neurolog Rev2016;172:594-606

[31] Bang ML.Animal models of congenital cardiomyopathies associated with mutations in Z-line proteins..J Cell Physiol2016;232:1-15

[32] Maerkens A,Olivé M,van der Ven PF,Milting H,Uszkoreit J,Barkovits K,Tonillo J,Meyer HE,Tegenthoff M,Müller T,Vorgerd M.Differential proteomic analysis of abnormal intramyoplasmic aggregates in desminopathy..J Proteomics2013;90:14-27 PMCID:PMC5120880

[33] Ton VK,Judge DP.Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction..Clin Med Insights Cardiol2015;8:39-44 PMCID:PMC4284988

[34] van den Bogaart FJ,Kley R,Schrading S,Voermans NC.Widening the spectrum of filamin-C myopathy: predominantly proximal myopathy due to the p.A193T mutation in the actin-binding domain of FLNC..Neuromusc Disorders2017;27:73-7

[35] Ruparelia AA,Ramm G.FLNC myofibrillar myopathy results from impaired autophagy and protein insufficiency..Hum Mol Genet2016;25:2131-42

[36] Jo BS,Bae JB,Jeon ES,Kim JJ,Choi SS.Data of methylome and transcriptome derived from human dilated cardiomyopathy..Data Brief2016;9:382-7 PMCID:PMC5035344

[37] Esslinger U,Korniat A,Kararigas G,Empana JP,Perret C,Bick AG,Kriebel J,Tiret L,O'Regan DP,Seidman JG,Lacolley P,Hengstenberg C,Hakonarson H,Arbustini E,Cook SA,Regitz-Zagrosek V,Charron P,Villard E.Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy..PLoS One2017;12:e0172995 PMCID:PMC5351854

[38] Smith LD,Kingsmore SF.Whole-exome sequencing and whole-genome sequencing in critically ill neonates suspected to have single-gene disorders..Cold Spring Harb Perspect Med2015;6:a023168 PMCID:PMC4743073